A Three-Month, Open-Label, Two Cohort Study to Investigate the Safety and Tolerability of Myfortic in Combination With Neoral (Cyclosporin) or Prograf (Tacrolimus) in Liver Transplant Recipients With GI [gastrointestinal] Intolerance.

Trial Profile

A Three-Month, Open-Label, Two Cohort Study to Investigate the Safety and Tolerability of Myfortic in Combination With Neoral (Cyclosporin) or Prograf (Tacrolimus) in Liver Transplant Recipients With GI [gastrointestinal] Intolerance.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2010

At a glance

  • Drugs Ciclosporin; Mycophenolate sodium; Tacrolimus
  • Indications Gastrointestinal disorders; Liver transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Feb 2010 Actual patient number (31) added as reported by ClinicalTrials.gov.
    • 24 Feb 2010 Actual end date (December 2009) added as reported by ClinicalTrials.gov.
    • 24 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top